Aveanna Healthcare Holdings (AVAH) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Aveanna Healthcare Holdings

NasdaqGS•Healthcare•Medical Care Facilities

$14.26-0.05(<0.01%)Pre-market

Market Cap

$3.11B

P/E

11.3x

P/S

1.2x

P/B

10.8x

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

How this company scores

GoodMetricSide Score: 69/100

Strongest: Profitability (23/25); weakest: Balance Sheet & Red Flags (7/25).

Profitability23/25

Growth22/25

Balance Sheet & Red Flags7/25

Cash & Earnings Quality17/25

Strengths

Growing revenueRising free cash flowHigh ROERising earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 11.3x5y range 5.2x – 192.3x

Currently below its 6-quarter median.

P/S · 1.2x5y range 0.4x – 1.2x

Currently above its 18-quarter median.

P/B · 10.8x5y range 1.3x – 199.1x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Earnings Quality

Red Flag

FCF consistently trails net income (avg 0.5x) — earnings may be inflated by non-cash items or aggressive accounting.

Leverage Risk

Red Flag

D/E ratio is 4.5 — heavily leveraged and vulnerable to rising rates or cash flow dips.

Price & Volume

Market Cap $3.11B

Metrics at a Glance

as of July 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $2.60B
Q. Revenue: $670.48M
TTM EBITDA: $285.15M
TTM Op. Income: $273.93M
Q. Op. Income: $79.98M
TTM Net Income: $274.76M
Q. Net Income: $40.29M
EPS: $0.19
Shares Out.: $217.80M

$2.60B in TTM revenue grew 19.5% YoY, reaching $670.48M last quarter. TTM EBITDA of $285.15M and TTM operating income of $273.93M show growth is flowing through to the bottom line. TTM net income of $274.76M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 32.6%
EBITDA Margin: 12.4%
Op. Margin: 11.9%
Net Margin: 6.0%

Op. margin of 11.9% is down 1.6% YoY — costs are rising relative to revenue. Net margin at 6.0% and gross margin of 32.6% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 12% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 11.3x
P/S Ratio: 1.2x
P/B Ratio: 10.8x

At 11.3x P/E, the stock trades below typical market levels. P/S of 1.2x and P/B of 10.8x provide additional context. P/E sits below typical market levels while revenue is growing. Over the past year, P/E is down 79% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $2.11B
Cash: $97.20M
Long-Term Debt: $1.28B
Book Value: $287.28M
D/E Ratio: 4.5
Debt/EBITDA: 15.5

With $2.11B in assets and $1.28B in long-term debt, D/E is 4.5and book value is $287.28M — elevated leverage, meaning significant financial risk in a downturn. Across the last 4 quarters, debt/equity has fallen for 3 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $80.93M
TTM Free Cash Flow: $158.38M
FCF Margin: 6.1%
FCF / Net Income: 0.6

TTM FCF of $158.38M on $80.93M in operating cash flow. The FCF / Net Income ratio of 0.6x means cash covers only part of net income — earnings quality needs attention. Across the last 8 quarters, free cash flow has risen for 7 consecutive quarters — an improving trend.